<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Avance Clinical</title>
    <link>https://www.biospace.com/employer/3076409/avance-clinical</link>
    <description>Avance Clinical</description>
    <language>en-US</language>
    <lastBuildDate>Thu, 11 Jan 2024 18:38:04 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/3076409/avance-clinical.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Avance Clinical: Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner Affecting Drug Development Schedules and Financial Plans</title>
      <link>https://www.biospace.com/avance-clinical-latest-analysis-reveals-65-percent-of-us-biotechs-struggle-to-identify-suitable-cro-partner-affecting-drug-development-schedules-and-financial-plans</link>
      <description>Avance Clinical, the leading Australian CRO for biotechs, announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program.</description>
      <pubDate>Thu, 11 Jan 2024 18:38:04 GMT</pubDate>
      <guid>https://www.biospace.com/avance-clinical-latest-analysis-reveals-65-percent-of-us-biotechs-struggle-to-identify-suitable-cro-partner-affecting-drug-development-schedules-and-financial-plans</guid>
    </item>
    <item>
      <title>Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones</title>
      <link>https://www.biospace.com/avance-clinical-and-medidata-celebrate-strategic-partnership-and-inhouse-expert-accreditation-milestones</link>
      <description>The leading Australian CRO for biotechs, and Frost &amp; Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts.</description>
      <pubDate>Fri, 26 Feb 2021 17:49:51 GMT</pubDate>
      <guid>https://www.biospace.com/avance-clinical-and-medidata-celebrate-strategic-partnership-and-inhouse-expert-accreditation-milestones</guid>
    </item>
    <item>
      <title>Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program</title>
      <link>https://www.biospace.com/avance-clinical-celebrates-globalready-success-as-40-biotechs-join-program</link>
      <description>More than 40 biotech clients are now taking advantage of Avance Clinical's GlobalReady program which delivers streamlined clinical development from early phase in Australia expanding to sites in North America for later phases. All with the one CRO and dedicated teams across both regions.</description>
      <pubDate>Wed, 11 Jan 2023 15:10:33 GMT</pubDate>
      <guid>https://www.biospace.com/avance-clinical-celebrates-globalready-success-as-40-biotechs-join-program</guid>
    </item>
    <item>
      <title>Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373</title>
      <link>https://www.biospace.com/enveric-biosciences-selects-australian-cro-avance-clinical-in-preparation-for-phase-1-study-of-eb-373</link>
      <description>Enveric Biosciences, Inc. today announced that it has entered into an agreement with Avance Clinical for its planned Phase 1 clinical trial of EB-373, the company’s lead candidate targeting the treatment of anxiety disorders.</description>
      <pubDate>Thu, 23 Mar 2023 10:36:09 GMT</pubDate>
      <guid>https://www.biospace.com/enveric-biosciences-selects-australian-cro-avance-clinical-in-preparation-for-phase-1-study-of-eb-373</guid>
    </item>
    <item>
      <title>Avance Clinical Briefs 45 Korean Biotechs on their GlobalReady Drug Development Pathway, from Korea and Australia to the US</title>
      <link>https://www.biospace.com/avance-clinical-briefs-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us</link>
      <description>Avance Clinical, the Australian and North American market-leading CRO for biotechs, was asked to present its GlobalReady drug development solution to more than 45 Korean biotechs</description>
      <pubDate>Thu, 19 Oct 2023 19:00:36 GMT</pubDate>
      <guid>https://www.biospace.com/avance-clinical-briefs-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us</guid>
    </item>
    <item>
      <title>Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia</title>
      <link>https://www.biospace.com/oragenics-partners-with-avance-clinical-for-phase-ii-concussion-trial-in-australia</link>
      <description>Oragenics, Inc., a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, announced a partnership with Avance Clinical, a leading Contract Research Organization, to conduct a Phase II clinical trial in Australia.</description>
      <pubDate>Tue, 07 May 2024 12:06:10 GMT</pubDate>
      <guid>https://www.biospace.com/oragenics-partners-with-avance-clinical-for-phase-ii-concussion-trial-in-australia</guid>
    </item>
    <item>
      <title>Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical</title>
      <link>https://www.biospace.com/avance-clinical-expands-specialist-cns-cardiometabolic-and-rare-diseases-cro-services-in-europe-with-julius-clinical</link>
      <description>Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS</description>
      <pubDate>Mon, 03 Jun 2024 15:52:05 GMT</pubDate>
      <guid>https://www.biospace.com/avance-clinical-expands-specialist-cns-cardiometabolic-and-rare-diseases-cro-services-in-europe-with-julius-clinical</guid>
    </item>
    <item>
      <title>Avance Clinical Announces Senior Appointment to North American Operations</title>
      <link>https://www.biospace.com/avance-clinical-announces-senior-appointment-to-north-american-operations</link>
      <description />
      <pubDate>Wed, 31 Jul 2024 11:29:58 GMT</pubDate>
      <guid>https://www.biospace.com/avance-clinical-announces-senior-appointment-to-north-american-operations</guid>
    </item>
    <item>
      <title>Avance Clinical Joins the Australian Clinical Trials Roadshow, Sharing Cost and Time Benefits for Early-Phase US Biotechs</title>
      <link>https://www.biospace.com/press-releases/avance-clinical-joins-the-australian-clinical-trials-roadshow-sharing-cost-and-time-benefits-for-early-phase-us-biotechs</link>
      <description />
      <pubDate>Fri, 13 Sep 2024 12:45:24 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/avance-clinical-joins-the-australian-clinical-trials-roadshow-sharing-cost-and-time-benefits-for-early-phase-us-biotechs</guid>
    </item>
    <item>
      <title>Avance Clinical Leads as the CRO of Choice for Early Phase Clinical Trials in Australia – Announced at Biotech Showcase 2025</title>
      <link>https://www.biospace.com/press-releases/avance-clinical-leads-as-the-cro-of-choice-for-early-phase-clinical-trials-in-australia-announced-at-biotech-showcase-2025</link>
      <description />
      <pubDate>Tue, 14 Jan 2025 19:57:15 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/avance-clinical-leads-as-the-cro-of-choice-for-early-phase-clinical-trials-in-australia-announced-at-biotech-showcase-2025</guid>
    </item>
  </channel>
</rss>
